MedTrace Logo

Overnight Fasting After Completion of Therapy: The OnFACT Study

NCT03523377 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2025-07-25

No results posted yet for this study

Summary

The purpose of this study is to test whether regularly not eating for at least 14 hours overnight ("intermittent fasting") is feasible and can improve blood sugar.

Conditions

  • Childhood Cancer Survivors

Interventions

OTHER

prolonged overnight fasting

Three phone calls using motivational interviewing, support via SMS text.

OTHER

usual care

Eat a heart-healthy diet and exercise for at least 30 minutes five days a week

Sponsors & Collaborators

Principal Investigators

  • Danielle Friedman, MD, MS · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-27
Primary Completion
2026-04-30
Completion
2026-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03523377 on ClinicalTrials.gov